These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23156353)

  • 21. [Oral contraceptives and cancer].
    Ludwig H
    Schweiz Rundsch Med Prax; 1989 Nov; 78(46):1273-5. PubMed ID: 2814116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contraception and prevention of women carcinoma (author's transl)].
    Quist C; Cohen J
    Contracept Fertil Sex (Paris); 1976 Sep; 4(5):369-71, 374-80. PubMed ID: 992194
    [No Abstract]   [Full Text] [Related]  

  • 23. [Steroid contraception and cancer (author's transl)].
    Andolsek L
    Jugosl Ginekol Opstet; 1978; 18(2):193-9. PubMed ID: 755125
    [No Abstract]   [Full Text] [Related]  

  • 24. [Does the "pill" promote the development of tumors?].
    Lauritzen C
    Med Klin; 1980 Aug; 75(16):6-7. PubMed ID: 6251352
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cancerogenesis of contraceptive pills and lessons learned].
    Nau JY
    Rev Med Suisse; 2005 Aug; 1(30):1991. PubMed ID: 16200945
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral contraceptives and cancer].
    Thomas DB
    Adv Contracept; 1993 Mar; 9 Suppl 1():31-48. PubMed ID: 8512029
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of gynecologic preventive examinations--perspectives].
    Hochuli E; Rageth C
    Geburtshilfe Frauenheilkd; 1990 Jun; 50(6):483-7. PubMed ID: 2376309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and reproductive system cancer. Benefits and risks.
    Williams JK
    J Reprod Med; 1991 Mar; 36(3 Suppl):247-52. PubMed ID: 2046078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
    Hertz R
    Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral contraceptives and endometrial and cervical cancer.
    Moghissi KS
    J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
    [No Abstract]   [Full Text] [Related]  

  • 31. Neoplastic effects of oral contraceptives.
    Grimes DA
    Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and reproductive cancers: weighing the risks and benefits.
    Coker AL; Harlap S; Fortney JA
    Fam Plann Perspect; 1993; 25(1):17-21, 36. PubMed ID: 8432372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Female genital cancer and life style factors. New discoveries in epidemiological front-line research].
    Wilhelmson B
    Lakartidningen; 1995 Mar; 92(12):1248-55. PubMed ID: 7707768
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tasks of cancer prevention examinations in the woman].
    Stoll P
    Fortschr Med; 1974 Mar; 92(9):353-7. PubMed ID: 4819502
    [No Abstract]   [Full Text] [Related]  

  • 35. [Screening for gynecologic cancer].
    Yajima A; Sato S; Masuda K; Nagai H; Mori T
    Gan No Rinsho; 1990 Aug; 36(10):1128-32. PubMed ID: 2214149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer screening for women older than 40 years of age.
    Runowicz CD; Goldberg GL; Smith HO
    Obstet Gynecol Clin North Am; 1993 Jun; 20(2):391-408. PubMed ID: 8367140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
    Sperling MA
    West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormonal contraception and cancer.
    Drife J; Guillebaud J
    Br J Hosp Med; 1986 Jan; 35(1):25-9. PubMed ID: 3955285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives in the 1980s.
    Kols M; Rinehart W; Piotrow PT; Coucette L; Quillin WF
    Popul Rep A; 1982; (6):189-222. PubMed ID: 7128916
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology].
    Hammerstein J; Bolt HM; Breckwoldt M; von Eickstedt KW; Elger W; Hoffmann B; Köbberling J; Knorr D; Nieschlag E; Nocke W
    Dtsch Med Wochenschr; 1987 May; 112(22):897-9. PubMed ID: 3034544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.